FDA Medical Product User Fee Objectives

Topic

FDA Accountability

Published

Mar 04, 2026

Arnold Ventures outlines our priorities for the upcoming reauthorization of the Food and Drug Administration’s (FDA) medical product user fee programs.

FDA user fee objectives outline plans to strengthen biosimilar and generic competition, focusing on regulatory improvements and transparency.

Download PDF

FDA Medical Product User Fee Objectives

Topic

Published

Share

What are you looking for?